Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
Patents for C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
12/2005
12/08/2005US20050272670 Synthesis and use of glycodendrimer reagents
12/06/2005CA2253573C Fucoidan-containing foods or beverages
12/01/2005WO2005113568A1 Novel galactoside inhibitors of galectins
12/01/2005US20050267301 Production of high molecular weight hyaluronates
12/01/2005CA2567694A1 Novel galactoside inhibitors of galectins
11/2005
11/30/2005EP1599490A1 Process for the preparation of anticonvulsant derivatives of topiramate
11/30/2005EP1335932B1 Isolation of lectins
11/23/2005EP1598054A2 Method of suppressing appetite
11/23/2005EP1597265A2 Glycosolated enkephalin agents
11/16/2005CN1696141A Iterative oligosaccharide synthesis
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/09/2005EP1593692A1 Chitin oligomer composition and/or chitosan oligomer composition, and process for producing the same
11/03/2005WO2005103063A2 Apparatus and method for mixed-bed lectin chromatography
11/03/2005WO2004066915A3 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof
11/03/2005US20050245737 Apparatus and method for mixed-bed lectin chromatography
11/02/2005EP1589934A2 Certain aminoalkyl glucosaminide phosphate compounds and their use
11/02/2005EP1173409B1 Oxidised carbohydrates
11/01/2005US6960654 Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide
10/2005
10/27/2005WO2005099338A2 New suger-chain primer
10/27/2005CA2542604A1 Novel saccharide primer
10/19/2005EP1585752A1 Polyene polyketides, processes for their production and their use as a pharmaceutical
10/19/2005EP1585530A2 Bioadhesive pharmaceutical compositions
10/19/2005EP1461045A4 Glucosamine organic acid adducts
10/19/2005CN1685054A Cell-free production of glucosamine
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005056525A3 Deacetylation of n-acetylglucosamine
10/13/2005US20050227943 Certain aminoalkyl glucosaminide phosphate compounds and their use
10/13/2005US20050226776 Use of microfabricated devices
10/12/2005CN1680416A Synthesis of fructosamine perfume compound and fumet function for tobaco
10/12/2005CN1222295C Neutrophil leucocyte functional inhibitor
10/11/2005US6953850 Protecting groups for carbohydrate synthesis
10/06/2005WO2005093102A2 Array print buffers
10/06/2005WO2005092931A1 Preparation process of oligoglycosaminoglycan, and reducing end glucuronic acid type oligochondroitin sulfate and pharmaceutical composition comprising the same
10/06/2005WO2004093787A3 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
10/06/2005US20050222398 Glycopeptide conjugates and uses thereof
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/05/2005EP1581544A1 Process for the synthesis of 2-deoxy-d-glucose
10/05/2005EP1581543A2 Methods of producing c-aryl glucoside sglt2 inhibitors
10/04/2005US6951934 Method for preparing functionalized β-(1,3)-glucan derivatives
09/2005
09/29/2005WO2005090376A1 An improved process for producing chlorinated sucrose
09/29/2005WO2005090374A1 An improved process for producing chlorinated sucrose
09/29/2005US20050215490 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
09/29/2005CA2560284A1 An improved process for producing chlorinated sucrose
09/28/2005EP1578513A2 INTEGRATION OF AT LEAST TWO PROCESSES TO RE−USE ACID
09/28/2005CN1675232A Derivatives of monosaccharides for drug discovery
09/28/2005CN1675231A Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor
09/22/2005US20050208633 Sugar kinases with expanded substrate specificity and their use
09/22/2005CA2533878A1 Fluorinated carbohydrate conjugates
09/15/2005WO2005085264A1 Sulfated oligosaccharide derivatives
09/15/2005WO2004111188A3 Process for the treatment of chitinaceous materials and for the deacetylation of chitin
09/15/2005US20050203290 Stable crystals of sucralose having improved handling properties
09/15/2005US20050203287 Such as topiramate, via reacting alcohol with sulfuryl chloride in presence of amine base and halogenated hydrocarbon solvent to produce chlorosulfate intermediate which is reacted with amine ina second halogenated hydrocarbon solvent
09/15/2005US20050202447 Array print buffers
09/15/2005CA2557989A1 Sulfated oligosaccharide derivatives
09/14/2005EP1573035A2 Brother of the regulator of imprinted sites (boris)
09/13/2005US6943248 continuously crystallizing sucralose from an aqueous solution by continuous removal and recirculation of the vessel contents, and providing a long residence time for sucralose in the system
09/09/2005WO2005082918A1 Polymerizable bola-form glycolipid, tubular aggregate thereof, and polymer thereof
09/07/2005CN1665828A Novel substituted sulfamate anticonvulsant derivatives
09/06/2005US6939858 For therapy and prophylaxis of hyperglycemia
09/06/2005US6939857 Compounds and their uses
09/01/2005WO2005080489A1 A solution of metal-polymer chelate(s) and applications thereof
09/01/2005WO2005056786A3 Sugar kinases with expanded substrate specificity and their use
09/01/2005US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
08/2005
08/31/2005EP1567045A2 Methods for diagnosing the presence or stage of cancer
08/25/2005US20050187168 Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture
08/25/2005US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical
08/23/2005US6933382 Process for the synthesis of 2-deoxy-D-glucose
08/18/2005WO2005000862A3 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
08/11/2005US20050176653 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
08/11/2005US20050176652 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
08/11/2005US20050175543 Agents for magnetic imaging method
08/10/2005EP1560837A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone
08/10/2005CN1653076A An antimicrobial agent
08/04/2005US20050171058 Method for preparing a glucosamine compounds and compound thus obtained
08/04/2005US20050171035 For therapy of bacterial infection in a mammal
08/04/2005US20050170069 Methods for buffer stabilized aqueous deacylation
08/04/2005US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability
08/03/2005CN1649600A Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
07/2005
07/27/2005CN1646553A Methods for buffer stabilized aqueous deacylation
07/27/2005CN1646552A Methods and compositions for altering the sweetness delivery profile of sucralose
07/27/2005CN1646551A Extractive methods for purifying sucralose
07/27/2005CN1646538A Topiramate salts and compositions comprising and methods of making and using the same
07/27/2005CN1646513A An antimicrobial agent
07/14/2005US20050154196 Process for producing sugar in which molecular weight is lowered
07/13/2005EP1551880A1 Novel carbohydrate compositions and a process of preparing same
07/13/2005EP1551852A2 Methods and products for mucosal delivery
07/13/2005EP1551228A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
07/13/2005CN1639179A Process for improving sucralose purity and yield
07/12/2005US6916920 Use of hydrazines in determining structures of aldose and ketose monosaccharides located at reducing ends of saccharides
07/07/2005WO2005061523A1 Glycosaminoglycan (gag) mimetics
07/07/2005US20050148546 Solid phase acid hydrolysis on cation exchange resin; high yield, stability and purity with fewer clean up steps; reduced acid use and recycle; low cost, industrial scale production of glucosamine and salts
07/07/2005US20050148545 Better tasting dietary supplements; combined with such as citric acid
07/07/2005US20050148052 Reusing hydrochloric, sulfuric or phosphoric acid in hydrolysis of fungal biomass and generation of glucosamine and citric acid; bioreactors
07/07/2005CA2551181A1 Glycosaminoglycan (gag) mimetics
07/06/2005EP1455800B1 Process for the preparation of glucosamine salts
06/2005
06/29/2005EP1546352A2 Cell-free production of glucosamine
06/29/2005EP1268497B1 Ternary ligand complexes useful as radiopharmaceuticals
06/29/2005CN1633244A Aqueous chondro protective compositions having defined pH limitations for efficacious delivery
06/23/2005WO2005056786A2 Sugar kinases with expanded substrate specificity and their use
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 37